Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Gene

Search results

No.

KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related

Adherens junction 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

Adherens junction 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

Adherens junction 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Adherens junction 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Adherens junction 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

Adherens junction 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

Adherens junction 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

Bladder cancer 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

Bladder cancer 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

Bladder cancer 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Bladder cancer 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Bladder cancer 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

Bladder cancer 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

Bladder cancer 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

Breast cancer 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

Breast cancer 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

Breast cancer 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Breast cancer 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Breast cancer 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

Breast cancer 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

Breast cancer 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

Cadherin signaling 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

Cadherin signaling 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

Cadherin signaling 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Cadherin signaling 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Cadherin signaling 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

Cadherin signaling 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

Cadherin signaling 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

Calcium signaling pathway 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

Calcium signaling pathway 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

Calcium signaling pathway 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Calcium signaling pathway 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Calcium signaling pathway 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

Calcium signaling pathway 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

Calcium signaling pathway 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

Central carbon metabolism in cancer 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

Central carbon metabolism in cancer 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

Central carbon metabolism in cancer 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Central carbon metabolism in cancer 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Central carbon metabolism in cancer 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

Central carbon metabolism in cancer 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

Central carbon metabolism in cancer 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

Endometrial cancer 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

Endometrial cancer 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

Endometrial cancer 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Endometrial cancer 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Endometrial cancer 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

Endometrial cancer 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

Endometrial cancer 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

ErbB signaling pathway 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

ErbB signaling pathway 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

ErbB signaling pathway 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

ErbB signaling pathway 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

ErbB signaling pathway 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

ErbB signaling pathway 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

ErbB signaling pathway 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

Focal adhesion 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

Focal adhesion 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

Focal adhesion 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Focal adhesion 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Focal adhesion 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

Focal adhesion 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

Focal adhesion 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

Gastric cancer 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

Gastric cancer 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

Gastric cancer 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Gastric cancer 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Gastric cancer 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

Gastric cancer 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

Gastric cancer 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

HIF-1 signaling pathway 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

HIF-1 signaling pathway 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

HIF-1 signaling pathway 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

HIF-1 signaling pathway 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

HIF-1 signaling pathway 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

HIF-1 signaling pathway 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

HIF-1 signaling pathway 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

Integrin signaling 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

Integrin signaling 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

Integrin signaling 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Integrin signaling 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

Integrin signaling 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

Integrin signaling 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

Integrin signaling 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

MAPK signaling pathway 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

MAPK signaling pathway 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

MAPK signaling pathway 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

MAPK signaling pathway 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

MAPK signaling pathway 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

MAPK signaling pathway 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

MAPK signaling pathway 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

MicroRNAs in cancer 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

MicroRNAs in cancer 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

MicroRNAs in cancer 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

MicroRNAs in cancer 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

MicroRNAs in cancer 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

MicroRNAs in cancer 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

MicroRNAs in cancer 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

Non-small cell lung cancer 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

100

Non-small cell lung cancer 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

101

Non-small cell lung cancer 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

102

Non-small cell lung cancer 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

103

Non-small cell lung cancer 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

104

Non-small cell lung cancer 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

105

Non-small cell lung cancer 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

106

Pancreatic cancer 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

107

Pancreatic cancer 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

108

Pancreatic cancer 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

109

Pancreatic cancer 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

110

Pancreatic cancer 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

111

Pancreatic cancer 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

112

Pancreatic cancer 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

113

Pathways in cancer 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

114

Pathways in cancer 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

115

Pathways in cancer 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

116

Pathways in cancer 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

117

Pathways in cancer 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

118

Pathways in cancer 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

119

Pathways in cancer 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

120

PI3K-Akt signaling pathway 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

121

PI3K-Akt signaling pathway 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

122

PI3K-Akt signaling pathway 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

123

PI3K-Akt signaling pathway 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

124

PI3K-Akt signaling pathway 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

125

PI3K-Akt signaling pathway 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

126

PI3K-Akt signaling pathway 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

127

Prostate cancer 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

128

Prostate cancer 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

129

Prostate cancer 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

130

Prostate cancer 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

131

Prostate cancer 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

132

Prostate cancer 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

133

Prostate cancer 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

134

Proteoglycans in cancer 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

135

Proteoglycans in cancer 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

136

Proteoglycans in cancer 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

137

Proteoglycans in cancer 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

138

Proteoglycans in cancer 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

139

Proteoglycans in cancer 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

140

Proteoglycans in cancer 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;

141

Tight junction 💬

[1] ERBB2 💬

Afatinib 💬

Afatinib

[1] 285 💬

142

Tight junction 💬

[1] ERBB2 💬

Afatinib dimaleate 💬

Afatinib

[1] 285 💬

143

Tight junction 💬

[1] ERBB2 💬

Lapatinib ditosylate 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

144

Tight junction 💬

[1] ERBB2 💬

Lapatinib 💬

Lapatinib

[3] 34, 74, 75 💬

Disease ID	Name
34	Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2;
74	Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma;Hyperprolactinemia;
75	Cushing disease;Cushing syndrome;

145

Tight junction 💬

[1] ERBB2 💬

Neratinib 💬

Neratinib

[1] 34 💬

146

Tight junction 💬

[1] ERBB2 💬

Neratinib maleate 💬

Neratinib

[1] 34 💬

147

Tight junction 💬

[1] ERBB2 💬

Tesevatinib 💬

Tesevatinib

[1] 67 💬

Disease ID	Name
67	Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD;Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD;